Treatment of non-small-cell lung cancer: a perspective on the recent advances and the experience with gefitinib

Worldwide, non-small-cell lung cancer (NSCLC) is a leading cause of cancer-related mortality and, until screening detects early disease, treatment for the majority of patients will consist of radiation therapy, chemotherapy or combinations thereof. Modern mono and doublet chemotherapy regimens have...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Onn, A, Tsuboi, M, Thatcher, N
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Nature Publishing Group 2004
Konular:
Paper
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC2750809/
https://ncbi.nlm.nih.gov/pubmed/15340373
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6602062
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller